ZOLEDRONATE OSTEO Sandoz 5 mg/100ml amp 100 ml
7680626260014
CH-62626
M05BA08
07.99.0.
Reimbursement limitations:
ACLASTA3
Pour le traitement de l'ostéoporose documentée, de l'ostéoporose cortico-induite et de la maladie de Paget.
1 / 3
google
Details
- Product number
- 6262601
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- acidum zoledronicum 5 mg ut acidum zoledronicum monohydricum, mannitolum, natrii citras dihydricus corresp. natrium 7 mg, aqua ad iniectabile, ad solutionem pro 100 ml.
Articles (1)
Zoledronat Osteo Sandoz 5 mg/100 ml, Infusionslösung
Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
7.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 220.65
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2012
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 62626
- Drug name
- Zoledronat Osteo Sandoz 5 mg/100 ml, Infusionslösung
- Galenic form
- LSINF
- ATC Code
- M05BA08
- Authorization status
- Z
- Authorization category
- Category C
- Dispensation category
- B
- First authorization
- 29/03/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ZOLEDRONATE OSTEO Sandoz 5 mg/100ml amp 100 ml
- Description (DE)
- ZOLEDRONAT OSTEO Sandoz 5 mg/100ml Amp 100 ml
- Market launch
- 29/03/2012
- Narcotic (BTM)
- No